Sarah Kalil is a seasoned med-tech executive with extensive experience in the development of disruptive technologies, fundraising, product development, regulatory product approvals, and commercializing products in new markets. Kalil's impressive educational background includes a Master of Jurisprudence in Pharmaceutical and Med Device Law from Seton Hall University School of Law and a BS in Engineering from the University of Vermont.

Kalil has held numerous advisory and leadership roles throughout her career, including serving as the co-founder and CEO of CoreMap and as an advisor for MobileODT, Biocogniv Inc, Binx Health, AExtrak, and Boston Microfluidics. She has also served on various boards and councils, such as the board of advisors for the College of Engineering and Mathematical Sciences at the University of Vermont and the council member at the Dana-Farber Cancer Institute.

Kalil's remarkable career journey also includes former VP roles at Hologic and Cadence Inc, as well as Chief Operating Officer positions at T2 Biosystems, Interlace Medical (Acquired by Hologic), and Boston Endo-Surgical Technologies. Additionally, she has experience with mergers and acquisitions, post-acquisition product line scale-up, and was a member of the SPARK panel at the University of Vermont.